Regulatory Lymphocytes of the Immune System' - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Regulatory Lymphocytes of the Immune System'

Description:

Transplantation. Tumor Immunity. Infectious disease. TCR. Piccirillo et al. Trends in Immunol. ... Transplantation. Infectious. disease. Autoimmunity. CD4 CD25 ... – PowerPoint PPT presentation

Number of Views:92
Avg rating:3.0/5.0
Slides: 33
Provided by: drcapic
Category:

less

Transcript and Presenter's Notes

Title: Regulatory Lymphocytes of the Immune System'


1
Regulatory Lymphocytes of the Immune System.
Dr. C. Piccirillo Canada Research
Chair Department of Microbiology
Immunology McGill University MIMM-414A Lecture
2- Oct. 23, 2006
2
Induced regulatory T cells
Thymic CD4 T cell pool
Peripherally-induced CD4 Treg cells ( iTreg )
TCR
Peripheral differentiation signals
APC
_
Activated Effector T cell
Autoimmunity Transplantation Tumor Immunity
Infectious disease
Piccirillo et al. Trends in Immunol. 2004.
3
A network of CD4 regulatory T cells control
immune reponses.
  • A. INDUCED - immunization, experimental
    manipulation
  • NK-T cells
  • CD8 T cells
  • ?? T cells
  • DN T cells
  • CD4
  • Th1 cell-mediated cross-regulation of Th2 cells
    (IL-4 lt-gt IFN?)
  • Th3 - Induced by oral tolerance
  • TGF-?1 producing (IL-10) and TGF-?1 dependent
    effect
  • Tr1 - Induced by Ag IL-10 and IL-10 dependent
    effect

4
B. NATURALLY-OCCURRING Endogenous in naïve
repertoire professional
Thymic CD4 T cell pool
Thymically-derived naturally-occurring CD4CD25
Treg cells (nTreg )
Peripherally-induced CD4 Treg cells ( iTreg )
Foxp3
GITR
CTLA-4
CD25
TCR
TCR
Peripheral differentiation signals
CD25 GITR CTLA-4 Foxp3
APC
_
_
Activated Effector T cell
Autoimmunity Transplantation Tumor Immunity
Infectious disease
Piccirillo et al. Trends in Immunol. 2004.
5
Journal of Immunology 1995 1551151
Lymph nodes from a 2 month old BALB/c
6
Naturally-occurring CD4 regulatory T cells.
Autoimmunity
  • Dominant self-tolerance
  • Unique lineage of CD25 (IL-2R?) T cells
  • 1-10 of thymic or peripheral CD4 T cells
  • In resting, endogenous T cell repertoire
  • Rodents, human and non-human primates

Allergy
Infectious disease
CD4CD25 Treg cells
Tissue regeneration
Mucosal Immunity
Transplantation
  • Gastritis
  • Oophritis
  • Orchitis
  • Thyroiditis
  • Pancreatitis
  • Colitis
  • Auto Abs
  • Depletion
  • Day3 thymectomy
  • Genetic anomalies
  • Irradiation
  • Infections
  • Drugs

Normal Immune responses
Tumor Immunity
7
CD4CD25 nTreg cellsMasterswitch of peripheral
tolerance
Immunity
Tolerance
8
Reliable biomarkers for CD4CD25 regulatory T
cells?
CD25
GITR
CTLA-4
CD4CD25 Regulatory T cell
NO marker after T cell activation. Only in the
naïve T cell repertoire. Need better marker.
Galectin-1
CD103
Ly6
4-1BB
Unidentified X,Y,Z ??
Neuropilin-1
OX-40
Piccirillo et al. Trends in Immunology July
2004
9
T cell activation induces expression of
functional T cell surface molecules
Activated CD4 T cell
MHC/peptide
CD40L
TCR
TCR
CD25
Resting CD4 T cell
APC
CD69 CD44
CD25 is not a marker of Treg after T cell
activation. Only in the naïve T cell repertoire.
10
Phenotypic and functional characteristics
Treg cells are partially-activated cells
Treg cells are anergic.
  • Hyporesponsive to TCR stimulation restored by
    IL-2.
  • Do not produce IL-2, IL-4, IFN-?, IL-10 (?),
    TGF?1 (?)

11
CD4CD25 regulatory T cells suppress T cell
functions. Consensus elements
CD8
24h
Cytokine Production
Proliferation
CD8/-
CD8/
CD4 or CD8 T cells
CPM
48h
CD4CD25- ( ? ) or CD4CD25 (? ) T cells
  • Requirement for TCR engagement
  • Antigen non-specific MHC unrestricted
  • Induce cell cycle arrest (G1-S transition)

(ng/ml)
IFN-?
g
IFN-
CD8
CD8/-
CD8/
CD4CD25 Immunoregulatory T Cells Suppress
Polyclonal T Cell Activation In Vitro by
Inhibiting Interleukin 2 Production Angela M.
Thornton and Ethan M. Shevach J. Exp. Med. 1998
188 287-296.
12
Cellular origin of CD4 regulatory T cells
CD4 Treg
?
Endogenous Naturally-occurring
Induced during Immune response
13
TReg cells are a normal product of thymic
selection.
Figure 1. TR cells may arise from relatively
high-avidity interactions with self-peptideMHC
complexes, just below the threshold for negative
selection (green area). This narrow avidity
selection window ensures that Tr cells will
constitute only a small fraction of the mature T
cell pool and have a greater sensitivity to
self-peptideMHC than potentially pathogenic
autoreactive T cells.
  • Thymic development and TCR specificity Unknown
  • Diverse T cell repertoire
  • Self-specific
  • Cross-reactive to foreign?
  • Altered negative selection?

14
Unique signals for CD4CD25 Treg cell
homeostasis.
  • MHC II engagement in periphery
  • Foxp3
  • Requirement for co-stimulation
  • CD40/CD40L
  • B7/CD28
  • IL-2 production
  • IL-2-/- mice
  • IL-2R signaling IL-2Ra, STAT5, IL-2gc
  • Functional correlate survival, mechanism?
  • Other signals TGF-b1

15
FoxP3 transcription factor
  • FoxP3 spontaneous mutations induces
    autoimmunity
  • IPEX in humans Immunodysregulation,
    polyendocrinopathy,
  • enteropathy,X-linked syndrome
  • Scurfy in mice.
  • FoxP3-/- develop spontaneous autoimmunity-
    defective Treg cells
  • FoxP3 is preferentially expressed in CD4CD25 T
    cells
  • FoxP3 Tg have ? cellular frequency of CD4CD25
    Treg cells.
  • FoxP3 Tg mice x CTLA-4-/- resolved/delayed
    autoimmunity
  • FoxP3 retroviral transduction in non-regulatory
    CD4CD25- T cells
  • induces regulatory potential.
  • - Phenotypically and functionally similar to
    naturally occuring lineage.
  • Genes induced by FoxP3 remain unknown.

16
Fontenot et al.
More selective and faithful marker than CD25
17
Hypothetical pathway to suppression.
v
Self-reactive Teff cell
Ag/TCR
nTreg
IL-2 transcription
CD4CD25
IL-2 protein
IL-2 driven expansion
T cell differentiation effector function
18
CD4CD25 mediated suppression is
contact-dependent. Requirement for APC?
T cell Effector
CD4 CD25
B
Pathways to T cell suppression
X
A
Antigen Presenting Cell Co-stimulation Adhesion
  • CD4CD25 cells modulate co-stimulation?
  • MHC class I/II, B7.1/2, CD40 expression is
    unaffected.
  • Suppression is still operative with fixed LPS
    blasts.
  • Not overcome with ? numbers of APCs.

Piccirillo et al. J.Immunology 1671137-1140.
19
Mechanism of CD4CD25 regulatory T cell
function ?
Cellular and molecular requirements of CD4CD25
nTreg cell suppressor function.
  • Requires TCR engagement
  • Antigen non-specific
  • Cell-cell contact dependent
  • Co-stimulation/APC independent
  • T-T suppressor synapse
  • Cytokine independent
  • Suppress IL-2 mRNA in T cells.
  • Suppression of effector functions
  • proliferation
  • inflammatory cytokines
  • differentiation

nTreg
Teff cell
Antigen Presenting Cell
CD4CD25
Suppressor Synapse
APC
CD4 Teff
CD4 CD25
20
In vitro and in vivo role of cytokines in
CD4CD25 regulatory T cell-mediated
suppression?
Effector T cell
CD4 CD25
Cytokines ?
  • IL-4, IL-10
  • Immunosuppressive effects on APC and T cells
  • Suppression is cytokine independent
  • Cytokine neutralization
  • Absence of cytokines in suppressor supernatants
  • Cytokine-deficient Treg cells
  • Transwell chamber experiments

Contribution of Transforming Growth Factor ?1
(TGF-?1) ?
Piccirillo et al. J.Exp. Med. 196237-250.
21
CD4CD25 Treg cells control bacterial-driven
intestinal inflammation.
CD4CD45Rbhigh CD4CD45Rblow
(CD25 subset)
Bacterially-driven, Th1 cell-mediated Inflammator
y bowel disease (IBD) Colitis T cell infiltration
of colon -gtweight loss
CD4CD45Rbhigh
SCID
Colitis
No colitis
Initial studies showed that anti-IL-10 or
anti-TGF-B1 abrogated Treg-mediated suppression
of disease.
Suppressor T cell-derived TGF-?1? Suppressor
T cell-derived IL-10 ?
Nakamura et al JEM 2001 Membrane-bound TGF
Simon Read et al. JEM 2000.
22
  • Requirement for
  • Transforming Growth Factor ?1
  • (TGF-?1) ?

Y
TGF-?R
TGF-?1
nTreg
Y
X
DNRIITg Smad3-/-
TGF-?1-/-
X
Smad3
CD4CD25- and CD4CD25 T cells produce TGF-b1?
Piccirillo et al. J.Exp. Med. 196237-250.
23
CD4CD25 Treg cell-mediated control of mucosal
inflammation. Mouse model of Inflammatory bowel
disease (IBD)
Is nTreg cell function TGF-? dependent in
vivo?
WT B6/Sv129
WT B6/Sv129 TGF-b1-/-
3-7 day old neonates
  • Colitis
  • T cell infiltration of colon
  • Th1 response to gut bacteria
  • Weight loss

CD4CD25- WT CD4CD25
CD4CD25- TGF-b1-/-CD4CD25
CD4CD25-
B6 RAG-/-
?
Colitis
No colitis
Kullberg M., and C.A. Piccirillo Euro. J.
Immunol. 2005
24
TGF-?1-/- CD4CD25 nTreg cells suppress IBD.
CD25 CD25 cells cells
WT WT
WT WT TGF-b1-/-
TGF-b1-/-
A
Body weight ( of day 4 weight)
?
?
?
?
Days post cells
CD25 CD25 cells cells
WT WT
WT WT TGF-b1-/-
TGF-b1-/-
B
Incidence of colitis ()
25
TGF-?1-/- CD4CD25 nTreg cells suppresscolonic
inflammation.
B.
A.
A
A.
B.
C.
D.
E.
Grade of inflammation
C.
D.
CD25 cells WT WT
WT CD25 cells
WT TGF-b1-/- TGF-b1-/-
B
E.
IFN-g / G3PDH mRNA ratio
CD25 cells WT WT
WT CD25 cells
WT TGF-b1-/- TGF-b1-/-

26
CD4CD25-mediated regulation of Smad3-deficient
effector T cells in vivo.
WT B6/Sv129 Smad3 -/-
WT B6/Sv129
4-6 weeks old
FACS sort
WT CD4CD25- CD4CD25
Smad 3-/- CD4CD25- CD4CD25
CD4CD25-
B6 RAG-/-
Colitis
?
No colitis
27
Smad3-/- effector T cells are highly susceptible
to suppression mediated by CD4CD25 T cells in
vivo.
A
CD25 CD25
WT Smad3-/- Smad3-/- WT
Smad3-/- Smad3-/- WT WT
Smad3-/- WT
?
Body weight ( of day 4 weight)
?
?
?
?
?
B
Days post cells
Powrie group observes abrogation of protection
with TGFR-/- Effector T cells Why?
Grade of inflammation
28
Tissue-specific CD4CD25 mediated disease
protection in the absence of IL-10.
CD4CD25- CD4CD25
CD4CD25- IL-10-/- CD4CD25
CD4CD25-
Nude
Gastritis IBD
No Gastritis IBD develops !
No Gastritis No IBD
29
Diversity of modes of action
  • Context-dependent regulation of organ-specific
    autoimmunity.
  • Tissue-specific differentiation of Treg?
  • Any role for bacteria?
  • IBD is a bacterially-driven disease, not
    gastritis.
  • Lessons from germ-free mice.
  • Genetic background
  • Possible subsets of CD4CD25 Treg
  • Cytokine versus Contact
  • Adaptable to inflammatory milieu.
  • Induction of other Treg cells.

30
Re-evaluation of CTLA-4 autoimmune phenotype
  • Could CTLA-4 deficiency result in defective Treg
    function and thus autoimmunity ? (rather than
    role of CTLA-4 on T cell autonomous regulation)
  • CTLA-4 phenotype rescued by complementing
    CTLA-4-/- BM with wild type BM (mixed BM chimera)
  • CTLA-4 deficient bone marrow can make CD25CD4
    (function vs development)

CTLA-4 is expressed constitutively on
CD4CD25CD45RBlow cells. Read et al. J. Exp.
Med. July 2000
31
CD4CD25 (CD45low) inhibit IBD AntiCTLA-4
treatment abrogates the Treg function.
Open control Ig Closed CTLA-4. Adoptive
transfer of CD4 T cell into scid mice.
32
Possible Mechanisms of Action of CD4 Regulatory
T Cells
Naturally-occurring Treg
CD25
IL-10 TGF-?1
Cellular contact
A
B
AB
MHC peptide
Activated effector T cells
TCR
Naive CD4 or CD8 T cells
APC
Tolerance Autoimmunity Transplantation Tumor
Immunity Infectious disease
IL-10 TGF-?1
Induced Treg
CD25
Write a Comment
User Comments (0)
About PowerShow.com